Dashboard
Manage Tickers

ICCMIceCure Medical Ltd.

Nasdaq icecure-medical.com


$ 0.76 $ 0.06 (7.76 %)    

Thursday, 13-Jun-2024 15:40:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.819
$ 0.76
$ 0.00 x 0
$ 0.00 x 0
$ 0.76 - $ 0.76
$ 0.52 - $ 1.57
57,308
na
37.45M
$ 11.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

icecure-medical-reports-data-from-its-kidney-cancer-clinical-study-presented-at-interventional-radiology-conference-dsud-minimally-invasive-approach-results-in-shorter-hospitalization-and-minor-impact-on-renal-function
IceCure Medical Reports Data From Its Kidn...
06/12/2024 12:32:55

ICESECRET interim results, as previously announced, demonstrated ProSense® to be safe and effective in treating kidney tumors w...

hc-wainwright--co-reiterates-buy-on-icecure-medical-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Icec...
06/05/2024 11:34:54

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.

icecure-medical-announces-fda-advisory-panel-meeting-to-review-prosense-system-for-tumor-cryoablation
IceCure Medical Announces FDA Advisory Pan...
06/04/2024 12:35:23

hc-wainwright--co-reiterates-buy-on-icecure-medical-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Icec...
05/29/2024 10:21:32

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.

icecure-medical-q1-eps-008-inline-sales-74300k-miss-87550k-estimate
Icecure Medical Q1 EPS $(0.08), Inline, Sa...
05/28/2024 12:45:33

Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is ...

icecure-is-expected-to-receive-a-total-of-132m-in-proceeds-from-terumo-during-this-initial-term-of-which-it-has-received-4m-to-date-with-an-additional-82m-expected-upon-the-completion-of-orders-as-well-as-1m-expected-for-milestone-based-payments
IceCure Is Expected To Receive A Total Of ...
05/07/2024 12:45:12

independent-study-results-in-japan-demonstrate-0-breast-cancer-local-recurrence-5-years-following-treatment-with-icecures-prosense-adding-to-continued-data-published-globally
Independent Study Results In Japan Demonst...
05/07/2024 12:45:06

Study published in the peer reviewed journal Breast CancerExcellent cosmetic outcomes, high degree of patient satisfaction, and...

hc-wainwright--co-reiterates-buy-on-icecure-medical-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Icec...
04/16/2024 15:03:56

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.

icecure-medical-reports-final-ice3-breast-cancer-cryoablation-trial-results-data-submitted-to-fda-requesting-marketing-authorization-to-treat-early-stage-breast-cancer
IceCure Medical Reports Final ICE3 Breast ...
04/15/2024 12:37:23

Data presentation at highly influential American Society of Breast Surgeons ("ASBrS") Annual Meeting by Dr. Richard Fin...

hc-wainwright--co-reiterates-buy-on-icecure-medical-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Icec...
04/04/2024 10:31:59

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.

icecure-medical-q4-eps-007-inline-sales-125m-beat-117m-estimate
Icecure Medical Q4 EPS $(0.07), Inline, Sa...
04/04/2024 03:27:12

Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. The com...

as-of-march-31-2024-icecure-medical-had-cash-and-cash-equivalents-of-approximately-11m-icecure-has-implemented-an-expense-reduction-plan-lowering-the-monthly-cash-utilization-and-ensuring-it-can-meet-its-primary-goals-in-2024
As Of March 31, 2024, IceCure Medical Had ...
04/03/2024 12:36:27

icecure-medical-fy-eps-032-inline-sales-323m-beat-314m-estimate
Icecure Medical FY EPS $(0.32), Inline, Sa...
04/03/2024 12:33:07

Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is ...

earnings-scheduled-for-april-3-2024
Earnings Scheduled For April 3, 2024
04/03/2024 09:36:00

Companies Reporting Before The Bell • Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $3.25 per share on...

icecure-submits-510k-with-fda-for-clearance-of-xsense-cryoablation-system-with-cryoprobes
IceCure Submits 510(k) With FDA For Cleara...
04/02/2024 12:35:10

alliance-global-partners-maintains-buy-on-icecure-medical-raises-price-target-to-29
Alliance Global Partners Maintains Buy on ...
03/20/2024 16:08:02

Alliance Global Partners analyst Ben Haynor maintains Icecure Medical (NASDAQ:ICCM) with a Buy and raises the price target f...

hc-wainwright--co-reiterates-buy-on-icecure-medical-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Icec...
03/20/2024 10:58:01

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.

icecure-medical-reports-topline-results-from-ice3-cryoablation-breast-cancer-study
IceCure Medical Reports Topline Results Fr...
03/19/2024 12:34:05

Expects to submit full dataset to the FDA in April for marketing authorization of ProSense® for minimally invasive treatment of...

icecure-receives-notice-of-patent-allowance-in-japan-for-cryogen-flow-control
IceCure Receives Notice Of Patent Allowanc...
03/12/2024 12:32:27

hc-wainwright--co-reiterates-buy-on-icecure-medical-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Icec...
03/05/2024 11:37:24

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)